AstraZeneca PLC
1454.00
23-12月-24 11:29:54
15 分の遅延
株式
+21.00
+1.47%
本日の幅
1439.00 - 1458.00
ISIN
N/A
ソース
NASD.OMX SE
-
AstraZeneca Targets $80 Bln Revenue By 2030, Plans To Launch 20 New Medicines
21 5 2024 03:02:29 提供 NASDAQ US Markets
-
AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
20 5 2024 02:42:36 提供 NASDAQ US Markets
-
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
19 5 2024 22:05:22 提供 NASDAQ US Markets
-
AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients
16 5 2024 03:51:29 提供 NASDAQ US Markets
-
AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide
08 5 2024 05:10:43 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
29 4 2024 03:15:01 提供 NetDania Notify
-
AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer
29 4 2024 02:45:52 提供 NASDAQ US Markets
-
AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer
29 4 2024 02:45:52 提供 NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 4 2024 12:52:49 提供 NASDAQ US Markets
-
25 4 2024 11:30:48 提供 NASDAQ US Markets
-
25 4 2024 11:15:48 提供 NASDAQ Stocks
-
AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook
25 4 2024 03:16:35 提供 NASDAQ US Markets
-
NetDania - New 12 months High: AstraZeneca PLC
25 4 2024 03:15:24 提供 NetDania Notify
-
ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection
24 4 2024 03:37:17 提供 NASDAQ US Markets
-
FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment
05 4 2024 22:16:14 提供 NASDAQ US Markets
-
Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
05 4 2024 09:38:12 提供 NASDAQ Stocks
-
AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
02 4 2024 10:15:53 提供 NASDAQ Stocks
-
Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock
26 3 2024 18:07:03 提供 NASDAQ Stocks
-
AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts
25 3 2024 03:55:20 提供 NASDAQ US Markets
-
Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca
20 3 2024 14:32:29 提供 NASDAQ Stocks